Nagashree Seetharamu, MD, on Anti-Glycan Antibody Profiling in De Novo Stage IV Non Small Cell Lung Cancer

2015 IASLC World Conference on Lung Cancer

Nagashree Seetharamu, MD, of the North Shore LIJ Health System, discusses serum AGA-signatures that may provide a minimally invasive test for early detection of lung cancer risk (Abstract P3.04-085).

Lorraine Cheryl Pelosof, MD, PhD, on Never-Smokers in NSCLC

Lorraine Cheryl Pelosof, MD, PhD, of UT Southwestern Medical Center, discusses her study findings, which demonstrate an increasing proportion of never-smokers among patients with n...

Lung Cancer

Guneet Walia, PhD

Guneet Walia, PhD, on Central Issues in Lung Cancer Care

Guneet Walia, PhD, of the Lung Cancer Foundation, summarizes some key presentations: bridging the quality chasm, patients’ attitudes and physicians’ perceptions on maintenance ther...

Lung Cancer

Christine D. Berg, MD

Christine D. Berg, MD, on Screening for Lung Cancer in Those at High Risk

Christine D. Berg, MD, of Johns Hopkins Medicine, discusses how increased insurance coverage should dramatically increase lung cancer screening. If done correctly—which will be a c...

Lung Cancer

Symptom Management

Philip Bonomi, MD

Philip Bonomi, MD, on Results of the Romana 1 and Romana 2 Trials

Philip Bonomi, MD, of Rush Medical College, summarizes the findings on anamorelin and its use in advanced NSCLC for improvement in anorexia/cachexia symptoms (Abstracts ORAL 29.01,...

Lung Cancer

Pasi A. Jänne, MD, PhD

Pasi A. Jänne, MD, PhD, on Integration of Next Generation Data Into the Clinic

Pasi A. Jänne, MD, PhD, of Dana-Farber Cancer Institute, summarizes a workshop he conducted on the state of the art in next-generation sequencing of lung cancer (Abstract WS 01.07)...

Apr

Today In Oncology

Nagashree Seetharamu, MD, on Anti-Glycan Antibody Profiling in De Novo Stage IV Non Small Cell Lung Cancer

Related Videos

Lorraine Cheryl Pelosof, MD, PhD, on Never-Smokers in NSCLC

Guneet Walia, PhD, on Central Issues in Lung Cancer Care

Christine D. Berg, MD, on Screening for Lung Cancer in Those at High Risk

Philip Bonomi, MD, on Results of the Romana 1 and Romana 2 Trials

Pasi A. Jänne, MD, PhD, on Integration of Next Generation Data Into the Clinic

Adverse Events in Patients With Melanoma Treated With Ipilimumab Results of a Toxicity Monitoring Program

Risk of Leukemia in Pediatric Patients With Down Syndrome

Anesthesiologist Volume and Adverse Short-Term Outcomes After Complex Surgery for Gastrointestinal Cancer

Neoadjuvant Nivolumab Plus Chemotherapy Boosts Pathologic Complete Response Rate for Patients With Resectable NSCLC

Copanlisib Rituximab Extends Progression-Free Survival vs Rituximab Placebo in Indolent Non-Hodgkin Lymphoma